Maximize Your Portfolio with Data Driven Insights:
- Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
- Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio
InMode ( (INMD) ) has shared an update.
On February 4, 2025, InMode Ltd. reported its financial results for the fourth quarter and full year of 2024. The company recorded a decline in revenues compared to 2023, with fourth quarter GAAP revenues at $97.9 million and full year revenues at $394.8 million, reflecting a 23% and 20% decrease respectively. Despite the challenges posed by macroeconomic conditions and industry-specific headwinds, InMode returned $285.4 million to shareholders through share repurchases, representing 19% of its share capital. The company plans to continue its capital return strategy with a new share repurchase program approved by its Board of Directors. InMode remains committed to innovation and is planning to launch new platforms targeting the medical aesthetic and wellness markets in 2025 to enhance its market positioning.
More about InMode
InMode Ltd. is a prominent global provider of innovative medical technologies, specializing in the aesthetics industry. The company focuses on delivering advanced solutions for aesthetic procedures and wellness, leveraging its strong market position to offer cutting-edge platforms such as Ignite and OptimasMAX.
YTD Price Performance: 1.47%
Average Trading Volume: 937,835
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $1.46B
Find detailed analytics on INMD stock on TipRanks’ Stock Analysis page.
